Evaluation of Second-Line Apatinib Plus Irinotecan As a Treatment for Advanced Gastric Adenocarcinoma or Gastroesophageal Conjunction Adenocarcinoma: a Prospective, Multicenter Phase II Trial
FRONTIERS IN ONCOLOGY（2023）
关键词
second-line apatinib plus irinotecan,gastric adenocarcinoma,gastroesophageal junction adenocarcinoma,treatment efficacy,safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要